Product Owner, SAP Finance Systems at Cellares

South San Francisco, California, United States

Cellares Logo
Not SpecifiedCompensation
Senior (5 to 8 years)Experience Level
Full TimeJob Type
UnknownVisa
Biotech, Life Sciences, PharmaceuticalIndustries

Requirements

  • 5+ years of hands-on experience in SAP FICO and Project Systems including S/4HANA
  • 2+ full lifecycle implementations in SAP FICO with strong US localization knowledge
  • Prior experience in a life sciences, pharma, or biotech environment
  • Demonstrated understanding of US GAAP, tax processing, and cost center structures specific to regulated industries
  • Experience working in cross-regional models involving Offshore teams
  • Solid grasp of Clean Core principles, and exposure to Fiori-based solutions
  • Exceptional communication, documentation, and client-facing skills
  • Must be based in or willing to relocate to the San Francisco Bay Area
  • Experience implementing SAP FICO solutions in biotech or advanced therapy environments
  • Strong ability to translate financial compliance (SOX, GxP) into scalable system configurations and controls
  • Knowledge of clinical trial accounting, transfer pricing, and intercompany billing
  • Exposure to SAP Central Finance, SAP Group Reporting, or SAP BTP extensions
  • Experience working with labeling and supply chain integration in a pharma setting
  • CPA or MBA in Finance is a plus
  • Self-awareness, integrity, authenticity, and a growth/entrepreneurial mindset

Responsibilities

  • Configure and support SAP FICO (GL, AR, AP, AA, PS, CO-CCA, CO-PCA, COPA, etc.) and Project Systems (Enable project-based cost tracking, WBS structures, and capital planning) for GMP and R&D initiatives
  • Design and implement finance processes in SAP aligned with GMP and GxP standards
  • Ensure SAP PS integration with FICO and fixed asset management modules for end-to-end visibility and financial compliance
  • Support compliance and audit readiness in alignment with SOX, GxP, and FDA financial regulations
  • Collaborate with adjacent functions including EWM, PTP, and Pharma Labeling to ensure accurate financial integration
  • Contribute to a Clean Core approach by minimizing customizations and leveraging SAP BTP for extensibility
  • Participate in fit-gap analysis, blueprint workshops, solution design, and stakeholder approvals
  • Support monthly/quarterly close, internal controls, intercompany processes, and asset accounting
  • Create and maintain documentation including functional specs, SOPs, test scripts, and training materials
  • Provide ongoing support, training, and change management for users
  • Support process harmonization and compliant financial practices across global and local reporting structures

Skills

SAP FICO
SAP PS
SAP BTP
GMP
GxP
SOX
FDA regulations
WBS structures
CO-CCA
CO-PCA
COPA
Asset Accounting
EWM
PTP
Clean Core

Cellares

Develops and manufactures cell therapies efficiently

About Cellares

Cellares develops and manufactures cell therapies in the biotechnology sector, operating as an Integrated Development and Manufacturing Organization (IDMO). Its proprietary "Smart Factory" technology features an automated single-use cartridge system, which increases productivity and reduces costs and process failures compared to traditional methods. The company serves a range of clients, including pharmaceutical companies, and aims to provide efficient and cost-effective manufacturing services for cell therapies. Cellares stands out by combining development and manufacturing processes under one roof, making it a competitive option in the industry.

South San Francisco, CaliforniaHeadquarters
2019Year Founded
$345.3MTotal Funding
SERIES_CCompany Stage
Industrial & Manufacturing, BiotechnologyIndustries
201-500Employees

Benefits

Health Insurance
Dental Insurance
Vision Insurance
401(k) Company Match
Stock Options

Risks

Emerging biotech startups threaten Cellares' market share with similar solutions.
Potential regulatory delays could impact scaling of new automated systems like Cell Q.
Supply chain vulnerabilities may disrupt production timelines for Cell Shuttle and Cell Q.

Differentiation

Cellares' Cell Shuttle offers 10x scalability over manual cell therapy manufacturing.
The Smart Factory technology integrates development and manufacturing, unlike traditional CDMOs.
Cell Q automates QC processes, addressing bottlenecks in cell therapy quality control.

Upsides

Partnership with Sony enhances precision in cell therapy manufacturing processes.
Strategic partnership with Bristol Myers Squibb provides financial boost and validation.
Ossama Eissa's appointment as COO accelerates global expansion and operational capabilities.

Land your dream remote job 3x faster with AI